Authors: ROUSSO P BUCLIN T NUSSBERGER J BRUNNERFERBER F BRUNNER HR BIOLLAZ J

Citation: P. Rousso et al., EFFECTS OF MDL-100,240, A DUAL INHIBITOR OF ANGIOTENSIN-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE ON THE VASOPRESSOR RESPONSE TO EXOGENOUS ANGIOTENSIN-I AND ANGIOTENSIN-II CHALLENGES IN HEALTHY-VOLUNTEERS, Journal of cardiovascular pharmacology, 31(3), 1998, pp. 408-417

Authors: GARDINER SM KEMP PA BRUNNERFERBER F BENNETT T

Citation: Sm. Gardiner et al., EFFECTS OF THE DUAL METALLOPEPTIDASE INHIBITOR, MDL-100,240, ON REGIONAL HEMODYNAMIC-RESPONSES TO VASOACTIVE PEPTIDES IN CONSCIOUS RATS, British Journal of Pharmacology, 122(8), 1997, pp. 1687-1693

Authors: GARDINER SM KEMP PA BRUNNERFERBER F BENNETT T

Citation: Sm. Gardiner et al., COMPARATIVE EFFECTS OF THE DUAL METALLOPEPTIDASE INHIBITOR, MDL-100,240 AND OF ENALAPRILAT ON REGIONAL AND ON CARDIAC HEMODYNAMICS IN CONSCIOUS, HYPERTENSIVE, TRANSGENIC ((MREN-2)27) RATS, British Journal of Pharmacology, 122(8), 1997, pp. 1694-1701

Authors: KLEINBLOESEM CH JAQUETMULLER F ALHAMDAN Y BALDAUF C GISCLON L WESNES K CURTIN CR STUBBS RJ WALKER SA BRUNNERFERBER F

Citation: Ch. Kleinbloesem et al., INCREMENTAL DOSAGE OF THE NEW ANTIPSYCHOTIC MAZAPERTINE INDUCES TOLERANCE TO CARDIOVASCULAR AND COGNITIVE EFFECTS IN HEALTHY-MEN, Clinical pharmacology and therapeutics, 59(6), 1996, pp. 675-685

Authors: BIOLLAZ J MUNAFO A BUCLIN T GERVASONI JP MAGNIN JL JAQUET F BRUNNERFERBER F

Citation: J. Biollaz et al., WHOLE-BLOOD PHARMACOKINETICS AND METABOLIC EFFECTS OF THE TOPICAL CARBONIC-ANHYDRASE INHIBITOR DORZOLAMIDE, European Journal of Clinical Pharmacology, 47(5), 1995, pp. 453-460